HCID 67096264, 화합물 → HCID 57780716, 화합물

HRID 2076107노트

반응식

HRID 2076107 반응식
CN(C)[CH:3]=[C:4]1[CH2:9][CH2:8][CH2:7][CH:6]([OH:10])[C:5]1=O.[N+]([O-])(O)=O.[N+]([O-])(O)=O.[CH3:21][O:22][C:23]1[CH:24]=[C:25]([NH:35][C:36]([NH2:38])=[NH:37])[CH:26]=[CH:27][C:28]=1[N:29]1[CH:33]=[C:32]([CH3:34])[N:31]=[CH:30]1>>[CH3:21][O:22][C:23]1[CH:24]=[C:25]([NH:35][C:36]2[N:38]=[CH:3][C:4]3[CH2:9][CH2:8][CH2:7][CH:6]([OH:10])[C:5]=3[N:37]=2)[CH:26]=[CH:27][C:28]=1[N:29]1[CH:33]=[C:32]([CH3:34])[N:31]=[CH:30]1

참가 물질

3

반응물 2

HCID 67096264HCID 67096264, 화합물HCID 178493228HCID 178493228, 화합물

생성물 1

HCID 57780716HCID 57780716, 화합물

실험 절차

The title compound was prepared from 2-[1-dimethylamino-methylidene]-6-hydroxy-cyclohexanone (188 mg, 1 mmol) and N-[3-methoxy-4-(4-methyl-imidazol-1-yl)-phenyl]-guanidine dinitrate (223 mg, 0.60 mmol) using in analogous manner the procedure described in example 45b). Obtained as a white solid (36 mg, 17%). MS ISP (m/e): 352.3 (100) [(M+H)+].

출처 및 근거

ORD 기록
ord-e9b1c5e4bbb54490863bc5371f2a88a8
출처 데이터셋
uspto-grants-2011_04
특허 번호
US07923450B2

반응 노트

불러오는 중…